InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,965.18
(
0.27%
)
Post# of 251798
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 59
Posts 11482
Boards Moderated 0
Alias Born 07/16/2006

jbog

Member Level

Re: None

Tuesday, 06/19/2018 5:03:27 AM

Tuesday, June 19, 2018 5:03:27 AM

Post# of 251798
Roche to buy rest of Foundation Medicine

Swiss drugmaker Roche (OTCQX:RHHBY) has agreed to pay $137 per share to buy the rest of Foundation Medicine (NASDAQ:FMI), a $2.4B transaction that values the U.S. company at $5.3B.

The offer represents a premium of 29% to FMI's closing price on Monday.
Foundation Medicine offers comprehensive genomic profiling assays to identify molecular alterations in a patient's cancer and match them with targeted therapies, immunotherapies and clinical trials.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up